AACR Poster 2021 – KSQ-4279

April 10, 2021

“Functional genomic characterization of the USP1 inhibitor KSQ-4279 reveals a distinct mechanism of action and resistance profile relative to other DDR targeting drugs”

© 2024 KSQ Therapeutics, Inc. All rights reserved.